UroSurge

UroSurge, Inc. was a medical device company based in Coralville, Iowa, that specialized in minimally invasive neuromodulation therapies for urological and gynecological conditions. The company is best known for developing the Stoller Afferent Nerve Stimulation (SANS) system, a technology designed to treat overactive bladder (OAB) and urge incontinence by stimulating the sacral nerves via a peripheral approach. UroSurge's portfolio included the Percutaneous SANS (PerQ SANS) for office-based treatment and the Subcutaneous SANS (SubQ SANS), an implantable version. The company was acquired by Olympus America in 1999, and its core technology later became the foundation for the Urgent PC Neuromodulation System.